Copy RSS Feed Link Below

"Anti-Obesity Drug Development: The Potential and the Challenge" by Chien Li

Sponsored by department(s) : Pharmacology

Event Date : September 26, 2019

Start Time : 4:00 pm

Time Duration: 60 minutes

Location : Pinn 1-17

Description: Hosted by Michael Scott, Chien Li, PhD is a Principal Research Scientist, Novo Nordisk Research Center, Oregon Health and Science University, Seattle, WA
Novo Nordisk’s research center in Seattle, Washington, is theepicenter of the company’s R&D activities in the US. Teams arepart of a global organization, partnering with colleagues acrossvarious international research centers. The team in Seattle is focusedon early discovery projects within the diabetes and obesity areas.Scientists apply cutting edge technologies to bring molecules tomarket. Right now, that means identifying protein and stem-cell basedtherapies for obesity, diabetes, and other chronic diseases, as wellas research on the next generation of medical devices.